189 related articles for article (PubMed ID: 12055224)
1. Catecholamines inhibit the antigen-presenting capability of epidermal Langerhans cells.
Seiffert K; Hosoi J; Torii H; Ozawa H; Ding W; Campton K; Wagner JA; Granstein RD
J Immunol; 2002 Jun; 168(12):6128-35. PubMed ID: 12055224
[TBL] [Abstract][Full Text] [Related]
2. Removal of the majority of epidermal Langerhans cells by topical or systemic steroid application enhances the effector phase of murine contact hypersensitivity.
Grabbe S; Steinbrink K; Steinert M; Luger TA; Schwarz T
J Immunol; 1995 Nov; 155(9):4207-17. PubMed ID: 7594576
[TBL] [Abstract][Full Text] [Related]
3. Calcium channel blockers suppress the contact hypersensitivity reaction (CHR) by inhibiting antigen transport and presentation by epidermal Langerhans cells in mice.
Katoh N; Hirano S; Kishimoto S; Yasuno H
Clin Exp Immunol; 1997 May; 108(2):302-8. PubMed ID: 9158102
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive intestinal peptide modulates Langerhans cell immune function.
Kodali S; Ding W; Huang J; Seiffert K; Wagner JA; Granstein RD
J Immunol; 2004 Nov; 173(10):6082-8. PubMed ID: 15528344
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 1 alpha but not transforming growth factor beta inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Grabbe S; Bruvers S; Granstein RD
J Invest Dermatol; 1994 Jan; 102(1):67-73. PubMed ID: 8288913
[TBL] [Abstract][Full Text] [Related]
6. Augmentation of cutaneous immune responses by ATP gamma S: purinergic agonists define a novel class of immunologic adjuvants.
Granstein RD; Ding W; Huang J; Holzer A; Gallo RL; Di Nardo A; Wagner JA
J Immunol; 2005 Jun; 174(12):7725-31. PubMed ID: 15944274
[TBL] [Abstract][Full Text] [Related]
7. Anti-allergic drug olopatadine suppresses murine contact hypersensitivity and downmodulates antigen-presenting ability of epidermal Langerhans cells.
Tokura Y; Kobayashi M; Ito T; Takahashi H; Matsubara A; Takigawa M
Cell Immunol; 2003 Jul; 224(1):47-54. PubMed ID: 14572800
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil impairs the maturation and function of murine dendritic cells.
Mehling A; Grabbe S; Voskort M; Schwarz T; Luger TA; Beissert S
J Immunol; 2000 Sep; 165(5):2374-81. PubMed ID: 10946260
[TBL] [Abstract][Full Text] [Related]
9. IL-10 inhibits tumor antigen presentation by epidermal antigen-presenting cells.
Beissert S; Hosoi J; Grabbe S; Asahina A; Granstein RD
J Immunol; 1995 Feb; 154(3):1280-6. PubMed ID: 7822797
[TBL] [Abstract][Full Text] [Related]
10. IL-12 prevents the inhibitory effects of cis-urocanic acid on tumor antigen presentation by Langerhans cells: implications for photocarcinogenesis.
Beissert S; Rühlemann D; Mohammad T; Grabbe S; El-Ghorr A; Norval M; Morrison H; Granstein RD; Schwarz T
J Immunol; 2001 Dec; 167(11):6232-8. PubMed ID: 11714785
[TBL] [Abstract][Full Text] [Related]
11. Enhanced epidermal Langerhans cell migration in IL-10 knockout mice.
Wang B; Zhuang L; Fujisawa H; Shinder GA; Feliciani C; Shivji GM; Suzuki H; Amerio P; Toto P; Sauder DN
J Immunol; 1999 Jan; 162(1):277-83. PubMed ID: 9886396
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the induction of delayed-type and contact hypersensitivity by calcitonin gene-related peptide.
Asahina A; Hosoi J; Beissert S; Stratigos A; Granstein RD
J Immunol; 1995 Apr; 154(7):3056-61. PubMed ID: 7897198
[TBL] [Abstract][Full Text] [Related]
13. Langerhans cells beta 2-adrenoceptors: role in migration, cytokine production, Th priming and contact hypersensitivity.
Maestroni GJ; Mazzola P
J Neuroimmunol; 2003 Nov; 144(1-2):91-9. PubMed ID: 14597102
[TBL] [Abstract][Full Text] [Related]
14. Pituitary adenylate cyclase-activating polypeptide inhibits cutaneous immune function.
Kodali S; Friedman I; Ding W; Seiffert K; Wagner JA; Granstein RD
Eur J Immunol; 2003 Nov; 33(11):3070-9. PubMed ID: 14579275
[TBL] [Abstract][Full Text] [Related]
15. Functional caspase-1 is required for Langerhans cell migration and optimal contact sensitization in mice.
Antonopoulos C; Cumberbatch M; Dearman RJ; Daniel RJ; Kimber I; Groves RW
J Immunol; 2001 Mar; 166(6):3672-7. PubMed ID: 11238606
[TBL] [Abstract][Full Text] [Related]
16. Interferon-gamma and interleukin-10 inhibit antigen presentation by Langerhans cells for T helper type 1 cells by suppressing their CD80 (B7-1) expression.
Ozawa H; Aiba S; Nakagawa ; Tagami H
Eur J Immunol; 1996 Mar; 26(3):648-52. PubMed ID: 8605933
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide inhibits tumor necrosis factor-alpha production and antigen presentation by Langerhans cells.
Deng L; Ding W; Granstein RD
J Invest Dermatol; 2003 Nov; 121(5):1060-5. PubMed ID: 14708607
[TBL] [Abstract][Full Text] [Related]
18. New technologies to prevent and treat contact hypersensitivity responses.
Takashima A; Mummert M; Kitajima T; Matsue H
Ann N Y Acad Sci; 2000; 919():205-13. PubMed ID: 11083110
[TBL] [Abstract][Full Text] [Related]
19. Expression of neurotrophic factors and neuropeptide receptors by Langerhans cells and the Langerhans cell-like cell line XS52: further support for a functional relationship between Langerhans cells and epidermal nerves.
Torii H; Yan Z; Hosoi J; Granstein RD
J Invest Dermatol; 1997 Oct; 109(4):586-91. PubMed ID: 9326395
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor gamma inhibits the migration of dendritic cells: consequences for the immune response.
Angeli V; Hammad H; Staels B; Capron M; Lambrecht BN; Trottein F
J Immunol; 2003 May; 170(10):5295-301. PubMed ID: 12734379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
